✦ LIBER ✦

Some methods of poverty analysis: An application to Iranian data, 1975–1976

✍ Scribed by Wouter Van Ginneken

Book ID: 116128385
Publisher: Elsevier Science
Year: 1980
Tongue: English
Weight: 634 KB
Volume: 8
Category: Article
ISSN: 0305-750X
DOI: 10.1016/0305-750x(80)90055-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Some methods for statistical analysis of

Some methods for statistical analysis of multimodal distributions and their application to grain-size data

✍ Clark, Malcolm W. 📂 Article 📅 1976 🏛 Springer 🌐 English ⚖ 1017 KB

AN APPLICATION OF THE CONTROL CHART METH

AN APPLICATION OF THE CONTROL CHART METHOD TO THE ANALYSIS OF FISHERIES DATA

✍ RICH, W. H. 📂 Article 📅 1943 🏛 American Association for the Advancement of Scienc 🌐 English ⚖ 116 KB

The evaluation of an alternative sum wit

The evaluation of an alternative sum with applications to the analysis of some data structures

✍ Wojciech Szpankowski 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 707 KB

Some cumulative logit models for panel-d

Some cumulative logit models for panel-data analysis: an application to a dynamic analysis of personal efficacy

✍ Kazuo Yamaguchi 📂 Article 📅 1997 🏛 Springer Netherlands 🌐 English ⚖ 697 KB

Analysis of Transition Data by the Minim

Analysis of Transition Data by the Minimum-Chi-Square Method: An Application to Welfare Spells in Belgium

✍ Bart L. W. Cockx 📂 Article 📅 1997 🏛 MIT Press 🌐 English ⚖ 508 KB

An automated method for nonparametric ki

An automated method for nonparametric kinetic analysis of clinical DCE-MRI data: Application to glioblastoma treated with bevacizumab

✍ Gregory Z. Ferl; Lu Xu; Michel Friesenhahn; Lisa J. Bernstein; Daniel P. Barbori 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 395 KB

## Abstract Here, we describe an automated nonparametric method for evaluating gadolinium‐diethylene triamine pentaacetic acid (Gd‐DTPA) kinetics, based on dynamic contrast‐enhanced–MRI scans of glioblastoma patients taken before and after treatment with bevacizumab; no specific model or equation s